Glucagon-Like Peptide-1 Receptor Analogues in Type 2 Diabetes: Their Use and Differential Features.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 8, p. 805, doi. 10.1007/s40261-019-00826-0
- By:
- Publication type:
- Article
Works matching IS 11732563 AND DT 2019 AND VI 39 AND IP 8
Results: 12
1
2
Response to: "Comment on: Drugs that Can Kill a Toddler with One Tablet or Teaspoonful: A 2018 Updated List".
- Published in:
- 2019
- By:
- Publication type:
- Letter
3
Comment on: "Drugs That Can Kill a Toddler with One Tablet or Teaspoonful: A 2018 Updated List".
- Published in:
- 2019
- By:
- Publication type:
- Letter
4
Assessing the Value of Time Series Real-World and Clinical Trial Data vs. Baseline-Only Data in Predicting Responses to Pregabalin Therapy for Patients with Painful Diabetic Peripheral Neuropathy.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 8, p. 775, doi. 10.1007/s40261-019-00812-6
- By:
- Publication type:
- Article
5
Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response?
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 8, p. 799, doi. 10.1007/s40261-019-00803-7
- By:
- Publication type:
- Article
6
Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 8, p. 713, doi. 10.1007/s40261-019-00801-9
- By:
- Publication type:
- Article
7
Appropriate Timing of Discontinuation of Tacrolimus Therapy for Refractory Ulcerative Colitis.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 8, p. 737, doi. 10.1007/s40261-019-00795-4
- By:
- Publication type:
- Article
8
Emerging Trends in Metformin Prescribing in the United States from 2000 to 2015.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 8, p. 757, doi. 10.1007/s40261-019-00799-0
- By:
- Publication type:
- Article
9
Systematic Review and Meta-analysis of Pharmacist-Led Transitions of Care Services on the 30-Day All-Cause Readmission Rate of Patients with Congestive Heart Failure.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 8, p. 703, doi. 10.1007/s40261-019-00797-2
- By:
- Publication type:
- Article
10
Pharmacokinetics of Imipenem in Critically Ill Patients with Life-threatening Severe Infections During Support with Extracorporeal Membrane Oxygenation.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 8, p. 787, doi. 10.1007/s40261-019-00796-3
- By:
- Publication type:
- Article
11
Development Strategy and Relative Bioavailability of a Pediatric Tablet Formulation of Ticagrelor.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 8, p. 765, doi. 10.1007/s40261-019-00800-w
- By:
- Publication type:
- Article
12
Lilly Insulin Glargine Versus Lantus<sup>®</sup> in Type 2 Diabetes Mellitus Patients: India and East Asia Subpopulation Analyses of the ELEMENT 5 Study.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 8, p. 745, doi. 10.1007/s40261-019-00798-1
- By:
- Publication type:
- Article